Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

miRNA marker for diagnosing cardiovascular diseases and application of miRNA marker

A technology of disease diagnosis and markers, applied in the medical field, can solve problems such as poor kidney function, contrast agent allergy, blood system toxicity, etc., and achieve the effect of easy promotion, simple method, and important theoretical guidance

Pending Publication Date: 2021-06-11
NINGXIA MEDICAL UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the treatment of atherosclerosis is mostly drug therapy. Common drugs include aspirin and clopidogrel, but the side effects of drugs are relatively large, causing allergic reactions, liver damage, kidney damage, gastrointestinal reactions, and blood system toxicity. The applicable population is small and cannot be widely popularized; carotid artery ultrasound and angiography, which are the gold standard for detecting vascular lesions, are only diagnostic for atherosclerosis that has undergone structural changes in arteries, and it is difficult to directly observe atherosclerosis that has not yet undergone structural changes. Atherosclerotic lesions; and angiography is traumatic, especially for patients who are allergic to contrast media and have poor renal function

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • miRNA marker for diagnosing cardiovascular diseases and application of miRNA marker
  • miRNA marker for diagnosing cardiovascular diseases and application of miRNA marker
  • miRNA marker for diagnosing cardiovascular diseases and application of miRNA marker

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0026] The technical solutions of the present invention will be further described in detail below with reference to the accompanying drawings and examples.

[0027] Cardiovascular disease diagnosis miRNA marker and its application, its specific technical solution is:

[0028] (1) 100 μmol / l Hcy intervene in endothelial cells to establish an endothelial apoptotic model, and cell viability dyeing and flow cytometry detection of this concentration Hcy can cause apoptosis of endothelial cells, laying the foundation for subsequent experiments.

[0029] (2) After 100 μmol / L Hcy intervene, RT-QPCR was detected by the expression level of MIR-491-5P. It is determined that MIR-491-5P play a role in Hcy in Endothelial cell apoptosis.

[0030](3) After transfection with MIR-491-5P MIMICS and MIR-491-5P Inhibitor, RT-QPCR detected the level of expression of MIR-491-5P. After determining the transfection of MIR-491-5P MIMICS, MIR-491-5P Inhibitor successfully laid the foundation for reverse...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

According to the miRNA marker for cardiovascular disease diagnosis and the application of the miRNA marker, (1) 100mu mol / l Hcy intervenes endothelial cells to establish an apoptosis model, and cell viability staining and flow cytometry are used for detecting that the concentration Hcy can cause endothelial cell apoptosis, so that a foundation is laid for subsequent experiments; (2) after the step (1), the expression level of the miR-491-5p is detected by RT-qPCR (Reverse Transcription-Quantitative Polymerase Chain Reaction); it is determined that miR-491-5p plays a role in endothelial cell apoptosis caused by Hcy; (3) after the miR-491-5p mimics and the miR-491-5p inhibitor are transfected, the expression level of the miR-491-5p is detected through RT-qPCR; after the fact that the miR-491-5p mimics and the miR-491-5p inhibitor are successfully transfected is determined, a foundation is laid for reversely verifying the effect of the miR-491-5p on the endothelial cell apoptosis caused by the Hcy; and (4) miR-491-5p mimics and miR-491-5p inhibitor are respectively transfected, the cell apoptosis condition is detected again by flow cytometry, and it is determined that the miR-491-5p acts on the endothelial cell apoptosis caused by Hcy. The miR-491-5p plays an important role in endothelial cell injury caused by Hcy, the invnetion provides a theoretical basis for detecting and diagnosing atherosclerosis at a molecular level in the future, and has a potential practical value.

Description

Technical field [0001] The invention belongs to the field of medical technology, and in particular, there is a miRNA marker for cardiovascular disease diagnosis and its application. Background technique [0002] Cardiovascular Disease (CVD) is a global incidence and the highest mortality. At present, the number of patients with cardiovascular disease in my country is 290 million, and mortality ranks first in all diseases, accounting for more than 40% of the death of residents. The pathogenesis of CVD is not fully understood. Its risk factors mainly include high blood pressure, diabetes, hypoxia, and old age, etc. Most cardiovascular diseases are related to the development of Atherosclerosis, AS. In recent years, with the improvement of people's living standards, the changes in food habits, the increase in work pressure, and the changes of social environment, AS The incidence rate has a significant increase, and the age is increasingly ganghua, thus early detection, preventing and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6883C12Q1/02
CPCC12Q1/6883G01N33/5064G01N33/5023C12Q2600/158C12Q2600/178G01N2800/32
Inventor 姜怡邓张慧萍刘圆张辉
Owner NINGXIA MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products